Prilenia
Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopmental disorders.
57 employees · est. 2018 · Boston, United States
Wize Pharma
Wize Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders.
2 employees · est. 1982 · Hod Hasharon, Israel
Wize Pharma is the older company (2018 vs 1982); Prilenia is the larger of the two.
Side-by-Side Comparison
| Metric | Prilenia | Wize Pharma |
|---|---|---|
| Founded | ||
| Founded | 2018 | 1982 older |
| Headquarters | ||
| Headquarters | Boston, United States | Hod Hasharon, Israel |
| Employees | ||
| Employees | 57 larger | 2 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $115.50M | $7.50M |
| Funding Rounds | ||
| Funding Rounds | 3 | 1 |
| Services | ||
| Services | Developing treatments for neurodegenerative diseases, Clinical research, Drug discovery and development | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with neurodegenerative diseases, Families affected by Huntington's Disease and ALS, Medical researchers and healthcare professionals | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Clinical-stage Biotech Company, Neurodegenerative Disorders, Neurodevelopmental Disorders, Pridopidine, Movement Disorders, Huntington’s Disease, ALS, Phase 3 Clinical Trial, Phase 2/3 Clinical Trial, Dr. Michael Hayden, Biotech Industry Veteran, Drug Development, Global R&D, Naarden, The Netherlands, Herzliya, Israel | Biopharmaceutical, Ophthalmic Disorders, Clinical-stage, LO2A, Drug Development, Distribution Strategy, Phase II Trial, Phase IV Study, Sjögren's Syndrome, CCh, In-licensing, Pharmaceutical Company, Israel, HaMerkaz |
| Website | ||
| Website | prilenia.com | wizepharma.com |
About Prilenia
Prilenia, founded in 2018, is a promising clinical-stage biotech company advancing the landscape of treatments for neurodegenerative and neurodevelopmental disorders. With headquarters in the United States, and operations spanning Naarden, the Netherlands, Herzliya, Israel, and Boston, MA, Prilenia...
About Wize Pharma
Wize Pharma is a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders. The company has in-licensed certain rights to purchase, market, sell, and distribute a formula known as LO2A, which is currently registered and marketed in Germany, Switzerland, Hungary, and t...
We will tell you when either one moves
BounceWatch watches Prilenia and Wize Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Prilenia and Wize Pharma — by email.
Frequently Asked Questions
Compare Prilenia with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Prilenia on 11 Sep 2024, and Wize Pharma on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.